| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8950872 | Clinical Lung Cancer | 2018 | 26 Pages |
Abstract
Genomic profiling using ctDNA analysis detected alterations in most patients with advanced-stage NSCLC, with targetable aberrations and resistance mechanisms identified. This approach has demonstrated its feasibility in Asia.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Herbert H. Loong, Victoria M. Raymond, Yukimasa Shiotsu, Daniel T.T. Chua, Peter M.L. Teo, Tony Yung, Stan Skrzypczak, Richard B. Lanman, Tony S.K. Mok,